IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI localized cancers: Results of the digestive non-colorectal cancer cohorts

被引：0
|
作者：
de la Fouchardiere, C. [1 ]
Zaanan, A. [2 ]
Cohen, R. [3 ]
Le Sourd, S. M. [4 ]
Tougeron, D. [5 ]
Soularue, E. [6 ]
Dubreuil, O. [7 ]
Williet, N. [8 ]
Samalin-Scalzi, E. [9 ]
Piessen, G. [10 ]
Hautefeuille, V. [11 ]
Jary, M. [12 ]
Ben Abdelghani, M. [13 ]
Evesque, L. [14 ]
Rochigneux, P. [15 ]
Blanc, E. [16 ]
Bibeau, F. [17 ]
DeMontfort, A. [18 ]
Coutzac, C. [19 ]
机构：
[1] Ctr Leon Berard, Med Oncol, Lyon, France
[2] Hop Europeen Georges Pompidou, AP HP, Digest Oncol, Paris, France
[3] Hop St Antoine, Med Oncol, Paris, France
[4] Ctr Eugene Marquis, Digest Oncol, Rennes, France
[5] CHU Poitiers, Jean Bernard Hop, Gastroenterol & Digest Oncol, Poitiers, France
[6] Inst Mutualiste Montsouris, Med Oncol, Paris, France
[7] Gh Diaconesses Croix St Simon, Med Oncol, Paris, France
[8] Hop Nord St Priest Jarez, Gastroenterol & Digest Oncol, St Priest En Jarez, France
[9] ICM Inst Canc Montpellier, Med Oncol, Montpellier, France
[10] CHU Claude Huriez, Digest Surg, Lille, France
[11] CHU Amiens Picardie, Gastroenterol & Digest Oncol, Amiens, France
[12] CHU Clermont Ferrand Site Estaing, Med Oncol, Clermont Ferrand, France
[13] ICANS Inst Cancerol Strasbourg Europe, Med Oncol, Strasbourg, France
[14] Ctr Anticancer Antoine Lacassagne, GI Oncol, Nice, France
[15] IPC Inst Paoli Calmettes, Med Oncol, Marseille, France
[16] Ctr Leon Berard, Clin Res, Lyon, France
[17] CHU Besancon, Pathol, Besancon, France
[18] Ctr Leon Berard, Biostat, Lyon, France
[19] Ctr Leon Berard, Digest Oncol, Lyon, France
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1448P
引用
收藏
页码：S899 / S900
页数：2
相关论文
共 50 条
  • [31] Plitidepsin in patients with advanced colorectal cancer (CRC): Results of an exploratory phase II trial
    Tabernero, Josep M.
    Rivera, Fernando
    Casado, Esther
    Sanchez, Antonio
    Bezares, Susana
    Pico, Cesar
    Paz-Ares, Luis
    ANNALS OF ONCOLOGY, 2006, 17 : 122 - 122
  • [32] PD-1 antibody combined with COX inhibitor in MSI-h/dMMR or high TMB colorectal cancer: A single arm phase II study.
    Wu, Zehua
    Deng, Yanhong
    Zhang, Jianwei
    Hu, Huabin
    Cai, Yue
    Ling, Jiayu
    Deng, Ru
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [33] Phase II Randomized Trial of Neoadjuvant Pembrolizumab plus /- Chemotherapy for Operable Stage IA3-IIA Non-Small Cell Lung Cancer
    Huynh, C.
    Rayes, R.
    Gaudreau, P.
    Hirsh, V.
    Ofiara, L.
    Owen, S.
    Shieh, B.
    Walsh, L.
    Spicer, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S647 - S647
  • [34] CYCLIC CONCOMITANT RADIOTHERAPY AND CHEMOTHERAPY - RESULTS OF A PHASE-I-II TRIAL IN CANCERS OF THE UPPER RESPIRATORY-DIGESTIVE TRACT
    VANNETZEL, JM
    JUILLARD, JC
    CLIN, R
    COLBERT, N
    DECROIX, Y
    ZUILI, H
    PRESSE MEDICALE, 1987, 16 (09): : 448 - 449
  • [35] High level of activity of nivolumab anti-PD-1 immunotherapy and favorable outcome in metastatic/refractory MSI-H non-colorectal cancer: Results of the MSI cohort from the French AcSe program
    Tournigand, C.
    Flechon, A.
    Oudard, S.
    Saada-Bouzid, E.
    Pouessel, D.
    Le Tourneau, C.
    Augereau, P.
    Beylot-Barry, M.
    Grob, J. J.
    Chibaudel, B.
    Soria, J-C.
    Simon, C.
    Couch, D.
    Hoog-Labouret, N.
    Tiffon, C.
    Chevret, S.
    Andre, T.
    Marabelle, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 506 - 506
  • [36] Neoadjuvant combined treatment for stage III non-small cell lung cancer (NSCLC): Results of a prospective phase II trial
    Thomas, M
    Rube, C
    Semik, M
    Klinke, F
    VonEiff, M
    VandeLoo, J
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 431 - 433
  • [37] A randomized phase II trial of neoadjuvant chemokine modulation in patients with localized prostate cancer undergoing radical prostatectomy.
    Jatwani, Karan
    Kalathil, Suresh
    Slomba, Ronald
    Farmer, Bailey
    Attwood, Kristopher
    Roy, Arya Mariam
    Singh, Prashant
    Kauffman, Eric
    Gopalakrishnan, Dharmesh
    George, Saby
    Levine, Ellis Glenn
    Guru, Khurshid
    Kalinski, Pawel
    Chatta, Gurkamal S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [38] A randomized phase II trial of neoadjuvant chemokine modulation in patients with localized prostate cancer undergoing radical prostatectomy.
    Jatwani, Karan
    Farmer, Bailey
    Roy, Arya Mariam
    Slomba, Ronald
    Attwood, Kristopher
    Levine, Ellis Glenn
    Kauffman, Eric
    Kalinski, Pawel
    Guru, Khurshid
    Gopalakrishnan, Dharmesh
    Chatta, Gurkamal S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [39] A phase Ib/II trial of lenvatinib plus pembrolizumab in non-small cell lung cancer.
    Brose, Marcia S.
    Vogelzang, Nicholas J.
    DiSimone, Christopher
    Jain, Sharad K.
    Richards, Donald A.
    Encarnacion, Carlos A.
    Rasco, Drew W.
    Shumaker, Robert Charles
    Dutcus, Corina E.
    Stepan, Daniel E.
    Guo, Matthew
    Schmidt, Emmett V.
    Taylor, Matthew H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [40] A Phase II Trial of Pembrolizumab for Untreated Brain Metastases from Non-Small Cell Lung Cancer
    Goldberg, Sarah B.
    Gettinger, Scott N.
    Mahajan, Amit
    Herbst, Roy
    Chiang, Anne
    Tsiouris, Apostolos J.
    Vortmeyer, Alexander
    Jilaveanu, Lucia
    Speaker, Stephanie
    Madura, Matthew
    Rowen, Elin
    Gerrish, Heather
    Yao, Xiaopan
    Chiang, Veronica
    Kluger, Harriet
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S234 - S235
12345